Interpretation of Antithrombotic Therapy in 2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases
10.3870/j.issn.1004-0781.2025.11.012
- VernacularTitle:2024年欧洲心脏病学会《外周动脉和主动脉疾病管理指南》抗血栓药物治疗解读
- Author:
Qinan YIN
1
;
Lizhu HAN
;
Youjin HUANG
;
Yuan BIAN
;
Xuefei HUANG
;
Yujie SONG
Author Information
1. 四川省医学科学院·四川省人民医院药学部,成都 610072
- Publication Type:Journal Article
- Keywords:
Guidelines for the Management of Peripheral Arterial and Aortic Diseases;
Antithrombotic therapy;
Anticoagulants;
Antiplatelet drugs;
Peripheral artery disease;
Aortic disease
- From:
Herald of Medicine
2025;44(11):1794-1798
- CountryChina
- Language:Chinese
-
Abstract:
In August 2024,the European Society of Cardiology Working Group on the management of Peripheral Artery and Aortic disease issued the"Guidelines for the management of peripheral and aortic arterial disease".The guideline stated that peripheral artery and aortic diseases were very common,significantly increasing cardiovascular disease morbidity and mortality in the general population,and their prevention and treatment strategies needed to be strengthened.This article interpreted the content of antithrombotic drug therapy in the guideline from the perspective of drug therapy,which could provide a reference for clinicians and pharmacists to formulate antithrombotic strategies.
